# Orphenadrine Citrate

NDC: 66267-158
Generic name: Orphenadrine Citrate
Labeler / Manufacturer: NuCare Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 19980619

FDA application: ANDA040284

## Active ingredients

- ORPHENADRINE CITRATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66267-158"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66267-158
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3eb1b1cc-ed7a-6f0f-e054-00144ff88e88